Epistem Holdings Plc (EHP) - Financial and Strategic SWOT Analysis Review by GlobalData

VIEWS: 145 PAGES: 43

More Info
									           Epistem Holdings Plc (EHP) - Financial and Strategic SWOT Analysis
                                         Review
        Reference Code: GDPH124915FSA                                                                                                                         Publication Date: JAN 2014

       Table of Contents
       Table of Contents ............................................................................................................................................................................... 1
          List of Tables .................................................................................................................................................................................. 3
          List of Figures ................................................................................................................................................................................. 3
       Section 1 - About the Company.......................................................................................................................................................... 5
       Epistem Holdings Plc - Key Facts ...................................................................................................................................................... 5
       Epistem Holdings Plc - Key Employees.............................................................................................................................................. 6
       Epistem Holdings Plc - Key Employee Biographies ........................................................................................................................... 7
       Epistem Holdings Plc - Major Products and Services ......................................................................................................................... 8
       Epistem Holdings Plc - Pharmaceutical Pipeline Products Data ...................................................................................................... 10
          Epistem Holdings Plc, Pipeline Products by Therapy Area ........................................................................................................... 10
          Epistem Holdings Plc, Pipeline Products by Development Phase ................................................................................................ 11
       Epistem Holdings Plc - Medical Equipment Pipeline Products Data................................................................................................. 13
          Epistem Holdings Plc Pipeline Products by Equipment Type ....................................................................................................... 13
          Epistem Holdings Plc Pipeline Products by Development Stage .................................................................................................. 15
       Epistem Holdings Plc - History ......................................................................................................................................................... 17
       Epistem Holdings Plc - Company Statement .................................................................................................................................... 19
       Epistem Holdings Plc - Locations And Subsidiaries ......................................................................................................................... 21
          Head Office ................................................................................................................................................................................... 21
          Other Locations & Subsidiaries ..................................................................................................................................................... 21
       Section 2 – Company Analysis ......................................................................................................................................................... 22
       Epistem Holdings Plc - Business Description ................................................................................................................................... 22
       Epistem Holdings Plc - Corporate Strategy ...................................................................................................................................... 23
       Epistem Holdings Plc - SWOT Analysis ........................................................................................................................................... 24
          SWOT Analysis - Overview........................................................................................................................................................... 24
          Epistem Holdings Plc - Strengths ................................................................................................................................................. 24
             Strength - Extensive Range of Product and Service ................................................................................................................. 24
             Strength - Biomarker Technology .............................................................................................................................................. 24
             Strength - Improvement in Liquidity Position ............................................................................................................................. 24
          Epistem Holdings Plc - Weaknesses ............................................................................................................................................ 24
             Weakness - Operational Inefficiency ......................................................................................................................................... 24
          Epistem Holdings Plc - Opportunities ........................................................................................................................................... 25
             Opportunity - Growth Prospects: Pharmaceutical Outsourcing ................................................................................................. 25
             Opportunity - Key Business Initiatives ....................................................................................................................................... 25
          Epistem Holdings Plc - Threats ..................................................................................................................................................... 26
             Threat - Competitive Landscape ............................................................................................................................................... 26
             Threat - Industry Consolidation ................................................................................................................................................. 26
             Threat - Stringent Government Regulations .............................................................................................................................. 26
       Epistem Holdings Plc - Key Competitors .......................................................................................................................................... 27
       Section 3 – Company Financial Ratios ............................................................................................................................................. 28
       Financial Ratios - Capital Market Ratios........................................................................................................................................... 28
       Financial Ratios - Annual Ratios ...................................................................................................................................................... 28


Epistem Holdings Plc (EHP) - Financial and Strategic SWOT                                                                                                    Reference Code: GDPH124915FSA
Analysis Review
Source : www.globalcompanyintelligence.com                                                                                                                                                                Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Performance Chart ........................................................................................................................................................................... 30
       Financial Performance...................................................................................................................................................................... 30
       Financial Ratios - Interim Ratios....................................................................................................................................................... 31
       Financial Ratios - Ratio Charts ......................................................................................................................................................... 32
       Section 4 – Company’s Lifesciences Financial Deals and Alliances ................................................................................................ 33
          Epistem Holdings Plc, Medical Equipment, Deals By Year, 2008 to YTD 2014 ............................................................................ 33
          Epistem Holdings Plc, Medical Equipment, Deals By Type, 2008 to YTD 2014 ........................................................................... 34
          Epistem Holdings Plc, Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014 .......................................................... 35
          Epistem Holdings Plc, Pharmaceuticals & Healthcare, Deals By Type, 2008 to YTD 2014 .......................................................... 36
       Epistem Holdings Plc, Recent Deals Summary ................................................................................................................................ 37
       Section 5 – Company’s Recent Developments ................................................................................................................................ 38
          Epistem Holdings Plc, Recent Developments ............................................................................................................................... 38
             Oct 22, 2013: Epistem Holdings announces preliminary results for the year to the 30 June 2013 ............................................ 38
             Oct 11, 2013: Epistem Announces Resignation of Director....................................................................................................... 38
             Sep 09, 2013: Epistem Provides Trading Update ..................................................................................................................... 38
             Aug 12, 2013: Epistem Receives a Prestigious FP7 Grant Award for the Development of Point of Care Hepatitis C Assays .. 39
             May 28, 2013: Epistem Co-Presents Biomarker Data At ASCO 2013 Annual Meeting ............................................................. 39
             Apr 08, 2013: Epistem To Present Biomarker Data, And Its New Preclinical Model Of Acute Myeloid Leukaemia, At AACR
             2013 Annual Meeting ................................................................................................................................................................ 40
             Feb 19, 2013: Epistem's Contract Research Division Gains GCLP Accreditation ..................................................................... 40
       Section 6 – Appendix ....................................................................................................................................................................... 42
          Methodology ................................................................................................................................................................................. 42
          Ratio Definitions ............................................................................................................................................................................ 42
          About GlobalData ......................................................................................................................................................................... 46
          Contact Us .................................................................................................................................................................................... 46
          Disclaimer ..................................................................................................................................................................................... 46




Epistem Holdings Plc (EHP) - Financial and Strategic SWOT                                                                                                    Reference Code: GDPH124915FSA
Analysis Review
Source : www.globalcompanyintelligence.com                                                                                                                                                                Page 2
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       List of Tables
       Epistem Holdings Plc, Key Facts........................................................................................................................................................ 5
       Epistem Holdings Plc, Key Employees............................................................................................................................................... 6
       Epistem Holdings Plc, Key Employee Biographies............................................................................................................................. 7
       Epistem Holdings Plc, Major Products and Services .......................................................................................................................... 8
       Epistem Holdings Plc, Number of Pipeline Products by Therapy Area............................................................................................. 10
       Epistem Holdings Plc, Number of Pipeline Products by Development Stage ................................................................................... 11
       Epistem Holdings Plc, Pipeline Products By Therapy Area and Development Phase ...................................................................... 12
       Epistem Holdings Plc Number of Pipeline Products by Equipment Type ......................................................................................... 13
       Epistem Holdings Plc Pipeline Products by Equipment Type ........................................................................................................... 14
       Epistem Holding
								
To top